title: Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.
authors.affiliation: Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Werner J
authors.initials: WJ
authors.lastname: Struss
authors.affiliation: Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Black
mesh_terms: D000970:Antineoplastic Agents; D002292:Carcinoma, Renal Cell; D006801:Humans; D007211:Indoles; D007680:Kidney Neoplasms; D009392:Nephrectomy; D011758:Pyrroles; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib